Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbal Medicine for COVID-19 Close Contacts
NCT05269511Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Randomised, open-label trial of Chinese herbal medicine oral spray in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hong Kong Baptist University. Primary endpoints: Proportion of subjects who have PCR confirmed SARS-CoV-2 infection at 3 weeks, Proportion of subjects with treatment-emergent adverse events (TEAEs) and severity of TEAEs at 3 weeks and 2 more. Started Mar 2022; status: completed.
02
Drugs
Chinese herbal medicine oral spray
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05269511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269511.